At the request of parents undergoing In Vitro Fertilization (IVF), gender selection is accomplished through a medical technology known as Preimplantation Genetic Screening (PGS/NGS). The PGS process takes place in conjunction with a fresh IVF cycle by an experienced embryologist while the embryos are developing in vitro. After several days of embryo development in vitro, all embryos undergo PGS to determine each embryo’s gender before transfer to the woman’s uterus for implantation into her uterine lining.
Family balancing is available to New Hope Fertility NYC patients through PGS in conjunction with IVF because gender identification of embryos is an inevitable by-product of the technology. Gender selection through PGS allows parents to select the sex of their child with more than 99 percent accuracy.Read more: How Gender Selection is Accomplished Through PGS
All the doctors at New Hope Fertility Center and patients hope that everyone would have a good result from their treatments, and we are all looking forward to be able to help many couples and women achieve their dream of being a parent.
Preimplantation genetic diagnosis (PGD) can be done during IVF treatment to identify embryos with genetic defects. The intention is to identify which embryos are healthiest and to avoid the use of embryos that will result in pregnancy loss. Additionally, the PGD process allows parents to avoid passing down a genetic disease.
In continuing to post about some of my unique and interesting cases, this article will address my standard practice of care in the treatment of patients who are suffering from polycystic ovarian syndrome (PCOS) after undergoing in vitro fertilization (IVF).
According to research, the miscarriage rate increases as a woman gets older. Women who are undergoing IVF treatment can benefit from Pre-implantation Genetic Screening (PGS). PGS evaluates an embryo to determine if it has the correct number of chromosomes. Having too many or too few chromosomes is evidence of a genetic defect. This test does not look for specific diseases, rather it aims to identify embryos that have an abnormal number of chromosomes. As a woman ages, the chance of her having embryos with an abnormal number of chromosomes rises.
Among the areas of focus that we have at New Hope Fertility Center is Poly Cystic Ovary Syndrome or PCOS. Often colleagues and patients alike want to know: how does NHFC manage individuals with PCOS during their IVF process? Let’s look at a case to see how New Hope Managed to successfully treat a difficult and common situation.
Preimplantation genetic diagnosis (PGD) can be done during IVF treatment to identify embryos with genetic defects. The intention is to identify which embryos are healthiest and to avoid the use of embryos that will result in pregnancy loss. Additionally, the PGD process allows parents to avoid passing down a genetic disease. As with any medical procedure, PGD has pros and cons. Ultimately, there is no one answer about the use of PGD. It is a highly personal decision that each couple must consider.
During in vitro fertilization (IVF) treatment, doctors have a number of tools at their disposal to increase success rates. One of these tools is preimplantation genetic diagnosis, commonly referred to as PGD. PGD is a method of testing embryos during IVF treatment to determine if an embryo has a genetic disease or chromosomal defect. Both of these issues can result in pregnancy loss, so transferring healthy embryos is ideal to increase the likelihood of a live birth and healthy child.